b'T he HonorHealth Research andCANCERInnovation Institute combinesThe Research Institute is home to one of the nations leading early drug development programsa distinction innovation and collaboration to bringnormally held by large academic medical centers. Since tomorrows cure to patients, today. Helping2015, first-in-human clinical trials here have been key to the FDA approval of more than two dozen new cancer patients navigating difficult health journeystreatments. These studies provide our community all over the world, the Institute has becomewith early access to potential advances before they are available in routine practice. Continuing to raise the bar, a patient destination for treatments oftenthe Institute offers more early-phase cancer clinical trials unavailable anywhere else. than any other Arizona cancer center. In 2020 they opened 23 new cancer trials and by the end of the year oversaw The Institute supports and oversees all medical111 active studies with 66 of those open to enrollment.research at HonorHealthfrom cancer andHEART AND VASCULARcardiovascular disease to neurological conditions,HonorHealth is taking action against cardiovascular traumatic injuries, COVID-19 research and more.disease, which affects nearly half of American adults. The A research program this robust is rarely seen atInstitute has contributed to the FDA approval of several a community hospital system. Since 2005, thecardiovascular devices and treatments and is a leader in Institute has created dynamic momentum byoffering new therapies. In fact, the Institute was first in the pushing the boundaries of medical knowledgeSouthwest and second in the nation to implant an MRI-to drive breakthrough discoveries that improve,safe pacemaker allowing more efficient care for patients extend and save lives. who need scans as part of their continuing health journey. In fact, patients from all 50 states and two dozenAdditionally, clinical trials here facilitated FDA approval of countries have visited the Institute to discussa new form of anticoagulant that doesnt require frequent individualized treatments with its medical teams.blood testing for patients at risk of developing blood clots.HonorHealth has attracted some of the mostCOVID-19distinguished physicians, leading scientists,Responding quickly to the COVID-19 pandemic, researchers and clinical teams in the nationHonorHealth Research and Innovation Institute reviewed operating within a unique hybrid academicapproximately 110 study projects from pharmaceutical model that offers patients personalized medicine,companies across the world in 2020. Several studies innovative treatments and new drugs and devicesoffering potentially lifesaving therapies were ultimately that are under development.launched, with more than 2,000 patients considered for With the help of donor generosity, partnershipsinvestigational treatment and more than 1,500 patients with prestigious universities, research facilitiestreated through their COVID-19 clinical trials.and pharmaceutical and medical deviceThe Institutes renowned physician-scientists give patients companies, the Institute moves well-beingaccess to groundbreaking therapies, trials and the latest forward in more ways than you can imagine.medical devices, along with a great deal of hope.As one of the nations foremost research organizations, The Institute embraces innovationOur focus in the Research Institute is making differences to improve medicine and change the future withfor patients right here and right now, states Mark Slater, solutions focused on bariatrics, cancer, heart andPhD, CEO of HonorHealth Research and Innovation vascular health, neurologic and spine conditionsInstitute. We are probably best known for our work in and trauma. developing cancer therapies. Often the very first people Research that spans multiple specialties benefitsin the world to try these treatments are done right here in our community and patients across the world. Scottsdale at the Institute.Your philanthropic support enables the HonorHealth Research and Innovation Institute to combine world-class care and ground-breaking research to transform the lives of patients facing serious health conditions.HonorHealth Foundation Magazine 9'